Injectable biodegradable hydrogels for embryonic stem cell transplantation: Improved cardiac remodelling and function of myocardial infarction

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 6, 2012, Pages 1310-1320

  Wang, Haibin ^a   Liu, Zhiqiang ^a   Li, Dexue ^a   Guo, Xuan ^b   Kasper, F Kurtis ^b   Duan, Cuimi ^a   Zhou, Jin ^a   Mikos, Antonios G ^b   Wang, Changyong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Rice University   (United States)

Author keywords

Cardiac tissue engineering; Cell encapsulation; Embryonic stem cell; Injectable hydrogels; Myocardial infarction

Indexed keywords

BIOMATERIAL; MACROGOL DERIVATIVE; OLIGO(POLY(ETHYLENE GLYCOL)FUMARATE); POLYESTER;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; EMBRYONIC STEM CELL; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HYDROGEL; INJECTION; METABOLISM; MOUSE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FEMALE; HYDROGELS; INJECTIONS; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84861541488     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01409.x     Document Type: Article

References (39)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 115: e69-171.
2. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
3. Zuba-Surma EK, Guo Y, Taher H, et al. Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med. 2011; 15: 1319-28.
4. Doss MX, Koehler CI, Gissel C, et al. Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med. 2004; 8: 465-73.
5. Lü S, Wang H, Lu W, et al. Both the transplantation of somatic cell nuclear transfer- and fertilization-derived mouse embryonic stem cells with temperature-responsive chitosan hydrogel improve myocardial performance in infarcted rat hearts. Tissue Eng Part A. 2010; 16: 1303-15.
6. Nelson TJ, Martinez-Fernandez A, Yamada S, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009; 120: 408-16.
7. Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?Circulation. 2000; 102: III56-61.
8. Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol. 2002; 34: 251-3.
9. Müller-Ehmsen J, Whittaker P, Kloner RA, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002; 34: 107-16.
10. Wang H, Zhou J, Liu Z, et al. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. 2010; 14: 1044-55.
11. Guo HD, Wang HJ, Tan YZ, et al. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A. 2011; 17: 45-58.
12. Zhang X, Wang H, Ma X, et al. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Exp Biol Med. 2010; 235: 1505-15.
13. Tsur-Gang O, Ruvinov E, Landa N, et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials. 2009; 30: 189-95.
14. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25: 1015-24.
15. Ou L, Li W, Zhang Y, et al. Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med. 2011; 15: 1310-8.
16. Kutschka I, Chen IY, Kofidis T, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation. 2006; 114: I167-73.
17. Wang H, Zhang X, Li Y, et al. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant. 2010; 29: 881-7.
18. Spadaccio C, Chello M, Trombetta M, et al. Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med. 2009; 13: 422-39.
19. Benton JA, DeForest CA, Vivekanandan V, et al. Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A. 2009; 15: 3221-30.
20. Garbern JC, Minami E, Stayton PS, et al. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011; 32: 2407-16.
21. Jo S, Shin H, Mikos AG. Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules. 2001; 2: 255-61.
22. Temenoff JS, Athanasiou KA, LeBaron RG, et al. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res. 2002; 59: 429-37.
23. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release. 2005; 101: 111-25.
24. Guo X, Park H, Liu G, et al. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials. 2009; 30: 2741-52.
25. Zhang MW, Park H, Guo X, et al. Adapting biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels for pigment epithelial cell encapsulation and lens regeneration. Tissue Eng Part C Methods. 2010; 16: 261-7.
26. Park H, Temenoff JS, Tabata Y, et al. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials. 2007; 28: 3217-27.
27. Park H, Guo X, Temenoff JS, et al. Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules. 2009; 10: 541-6.
28. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006; 12: 459-65.
29. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979; 44: 503-12.
30. Teng CJ, Luo J, Chiu RC, et al. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg. 2006; 132: 628-32.
31. Temenoff JS, Park H, Jabbari E, et al. Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules. 2004; 5: 5-10.
32. Park H, Temenoff JS, Holland TA, et al. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials. 2005; 26: 7095-103.
33. Zhang M, Methot D, Poppa V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001; 33: 907-21.
34. Leor J, Tuvia S, Guetta V, et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol. 2009; 54: 1014-23.
35. Dixon JA, Gorman RC, Stroud RE, et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation. 2009; 120: S220-9.
36. Ohnishi S, Sumiyoshi H, Kitamura S, et al. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett. 2007; 581: 3961-6.
37. Novotny NM, Ray R, Markel TA, et al. Stem cell therapy in myocardial repair and remodeling. J Am Coll Surg. 2008; 207: 423-34.
38. Tang J, Wang J, Guo L, et al. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol Cells. 2010; 29: 9-19.
39. He Q, Trindade PT, Stumm M, et al. Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression. J Cell Mol Med. 2009; 13: 188-201.